Galantamine for routine neuromuscular block reversal and treatment of emergence delirium in children after ENT surgery: a retrospective observational study

Background. Emergence delirium is a common complication of general anesthesia in children. Preschool age and ear, nose and throat (ENT) procedures are risk factors [1, 2, 3, 4]. The hypothesis linking delirium to central cholinergic deficiency provides a rationale for studying galantamine, an acetylcholinesterase inhibitor that crosses the blood-brain barrier and is used to reverse neuromuscular blockade. We assessed the association between its routine administration and emergence delirium in children after ENT surgery under sevoflurane anesthesia. Objective. To compare emergence delirium frequency and Pediatric Anesthesia Emergence Delirium (PAED) scores after elective ENT surgery with and without routine reversal of neuromuscular blockade with galantamine, and to describe the course of delirium episodes following therapeutic administration. Methods. This retrospective observational study included 207 children aged 2-17 years who underwent elective ENT surgery, predominantly adenoidectomy, tonsillotomy or tonsillectomy, under sevoflurane-based general anesthesia between October 2025 and January 2026. Data were extracted retrospectively from medical records into a study worksheet. PAED scores were checked against clinical descriptions and corrected where discrepancies were identified. The groups reflected the practices of two anesthesiologists. All children in the prophylactic group (n = 102) received galantamine to reverse neuromuscular blockade. In the group without prophylactic administration (n = 105), routine reversal was not performed; galantamine was administered as needed for impaired emergence or suspected residual neuromuscular blockade. The analysis used assessments performed after extubation in the operating room, before treatment for impaired emergence. The primary outcome was PAED > 10, interpreted alongside the clinical descriptions. Results. Prophylactic use. PAED > 10 was recorded in 0 of 102 children receiving routine reversal and 19 of 105 without prophylactic administration (18.1%, p < 0.0001). Median PAED scores were 7 [6-8] and 8 [6-9], respectively (p = 0.0015). Therapeutic use. Intravenous galantamine (2.5-10 mg) was administered in 17 episodes of delirium with motor agitation and impaired interaction. Resolution was documented in all 17 cases. Reduced agitation was accompanied by restoration of meaningful interaction. No sedatives were used to treat delirium. With ondansetron and dexamethasone prophylaxis, emetic events were recorded during the first postoperative hour in 17.6% and 21.9% of children, respectively (p = 0.49). No serious adverse events were documented. Conclusion. No PAED scores > 10 were recorded with routine reversal of neuromuscular blockade using galantamine. Following therapeutic administration, delirium resolution was accompanied by restoration of meaningful interaction without sedatives. These retrospective observational findings support further investigation of prophylactic and therapeutic galantamine use. The observations of restored interaction prompted the hypothesis that galantamine could act as an agent promoting emergence from anesthesia.

Authors

Publication Details

Journal
medRxiv
Published
2026-11-12
DOI
https://doi.org/10.64898/2026.11.12.26367732
Primary Topic
Anesthesia and Sedative Agents
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Galantamine for routine neuromuscular block reversal and treatment of emergence delirium in children after ENT surgery: a retrospective observational study

Ekaterina Anatolyevna Kairysh, Andrei Alexandrovich Neverov
medRxiv
Anesthesia and Sedative Agents
preprint

Galantamine for routine neuromuscular block reversal and treatment of emergence delirium in children after ENT surgery: a retrospective observational study

Ekaterina Anatolyevna Kairysh, Andrei Alexandrovich Neverov
preprint en

Abstract

Background. Emergence delirium is a common complication of general anesthesia in children. Preschool age and ear, nose and throat (ENT) procedures are risk factors [1, 2, 3, 4]. The hypothesis linking delirium to central cholinergic deficiency provides a rationale for studying galantamine, an acetylcholinesterase inhibitor that crosses the blood-brain barrier and is used to reverse neuromuscular blockade. We assessed the association between its routine administration and emergence delirium in children after ENT surgery under sevoflurane anesthesia. Objective. To compare emergence delirium frequency and Pediatric Anesthesia Emergence Delirium (PAED) scores after elective ENT surgery with and without routine reversal of neuromuscular blockade with galantamine, and to describe the course of delirium episodes following therapeutic administration. Methods. This retrospective observational study included 207 children aged 2-17 years who underwent elective ENT surgery, predominantly adenoidectomy, tonsillotomy or tonsillectomy, under sevoflurane-based general anesthesia between October 2025 and January 2026. Data were extracted retrospectively from medical records into a study worksheet. PAED scores were checked against clinical descriptions and corrected where discrepancies were identified. The groups reflected the practices of two anesthesiologists. All children in the prophylactic group (n = 102) received galantamine to reverse neuromuscular blockade. In the group without prophylactic administration (n = 105), routine reversal was not performed; galantamine was administered as needed for impaired emergence or suspected residual neuromuscular blockade. The analysis used assessments performed after extubation in the operating room, before treatment for impaired emergence. The primary outcome was PAED > 10, interpreted alongside the clinical descriptions. Results. Prophylactic use. PAED > 10 was recorded in 0 of 102 children receiving routine reversal and 19 of 105 without prophylactic administration (18.1%, p < 0.0001). Median PAED scores were 7 [6-8] and 8 [6-9], respectively (p = 0.0015). Therapeutic use. Intravenous galantamine (2.5-10 mg) was administered in 17 episodes of delirium with motor agitation and impaired interaction. Resolution was documented in all 17 cases. Reduced agitation was accompanied by restoration of meaningful interaction. No sedatives were used to treat delirium. With ondansetron and dexamethasone prophylaxis, emetic events were recorded during the first postoperative hour in 17.6% and 21.9% of children, respectively (p = 0.49). No serious adverse events were documented. Conclusion. No PAED scores > 10 were recorded with routine reversal of neuromuscular blockade using galantamine. Following therapeutic administration, delirium resolution was accompanied by restoration of meaningful interaction without sedatives. These retrospective observational findings support further investigation of prophylactic and therapeutic galantamine use. The observations of restored interaction prompted the hypothesis that galantamine could act as an agent promoting emergence from anesthesia.

medRxiv
Good health and well-being
Anesthesia and Sedative Agents
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon